US502504A
(en)
|
|
1893-08-01 |
|
Hermann thoms |
DE487014C
(de)
|
1927-10-23 |
1929-12-09 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von Harnstoffderivaten
|
US1792156A
(en)
*
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
DE511468C
(de)
|
1928-01-18 |
1930-10-30 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol
|
DE523437C
(de)
|
1928-12-25 |
1931-05-05 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor- und 5-Brom-2-amino-1-alkyloxy- und 1-aralkyloxybenzolen
|
US2093265A
(en)
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
US2288422A
(en)
*
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
US2973386A
(en)
*
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
US2502504A
(en)
*
|
1946-10-18 |
1950-04-04 |
John L Botner |
Hogshead
|
DE925476C
(de)
|
1950-04-29 |
1955-03-21 |
Variapat Ag |
Verfahren zur Herstellung von farblosen, wasserloeslichen, trifluormethyl- und sulfonsaeuregruppenhaltigen, aliphatischen oder aromatischen Carbonsaeure- bzw. Sulfonsaeurearyliden
|
US2683082A
(en)
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
US2722544A
(en)
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
US2781330A
(en)
*
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
NL185660B
(nl)
*
|
1953-03-06 |
|
Great Lakes Chemical Corp |
Werkwijze voor het bereiden van alkali- of aardalkalimetaalbromiden.
|
US2745874A
(en)
*
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
NL193403A
(fr)
*
|
1953-12-22 |
1924-02-17 |
|
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
US2877268A
(en)
*
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
US2960488A
(en)
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
NL254871A
(fr)
|
1959-08-14 |
|
|
|
NL277504A
(fr)
|
1961-04-21 |
|
|
|
CH520657A
(de)
|
1961-09-11 |
1972-03-31 |
Wander Ag Dr A |
Verfahren zur Herstellung mehrbasischer Verbindungen
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
US3284433A
(en)
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
FR90420E
(fr)
|
1965-06-09 |
1968-02-21 |
|
|
US3424761A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3424762A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
US3424760A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3743498A
(en)
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
SE370866B
(fr)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
DE1768244A1
(de)
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
US3754887A
(en)
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
US3646059A
(en)
*
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
US3668222A
(en)
*
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
BE754782A
(fr)
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
US3860645A
(en)
*
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
US4116671A
(en)
|
1973-07-27 |
1978-09-26 |
Shionogi & Co., Ltd. |
3-Isoxazolylcarbamate derivatives
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
US4212981A
(en)
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
JPS5031039A
(fr)
|
1973-07-27 |
1975-03-27 |
|
|
US4001256A
(en)
*
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
US4009847A
(en)
*
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
US3990879A
(en)
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
US4111683A
(en)
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
DE2637947C2
(de)
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
US4173637A
(en)
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
JPS5840946B2
(ja)
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
N−ベンゾイル−n′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
US4071524A
(en)
*
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
US4183854A
(en)
*
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
US4042372A
(en)
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
JPS5562066A
(en)
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
DE2848330A1
(de)
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
FI800559A
(fi)
|
1979-03-14 |
1980-09-15 |
Hoffmann La Roche |
Urinaemnederivat
|
JPS55124763A
(en)
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
US4468380A
(en)
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
GB2080808B
(en)
|
1980-01-25 |
1984-01-04 |
Reanal Finomvegyszergyar |
Process for the preparation of n-aryl-n-(mono- or disubstituted)-urea derivatives
|
ATE9131T1
(de)
|
1980-05-14 |
1984-09-15 |
Ciba-Geigy Ag |
Phenylbenzoylharnstoffe.
|
DE3174885D1
(en)
|
1981-02-03 |
1986-07-31 |
Ici Plc |
Process for the extraction of metal values and novel metal extractants
|
US4526997A
(en)
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
US4511571A
(en)
*
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
US4473579A
(en)
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
DE3211851A1
(de)
*
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
JPS58203957A
(ja)
*
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
IL69621A0
(en)
|
1982-09-02 |
1983-12-30 |
Duphar Int Res |
Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives
|
CA1254212A
(fr)
*
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amines derives, leur sels, procede de preparation et agent anti-ulcereux les contenant
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
US4499097A
(en)
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
GB8325496D0
(en)
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
CH663353A5
(de)
|
1984-03-28 |
1987-12-15 |
Joaquin Amat Larraz |
Mittel gegen krebs.
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
JPS6193163A
(ja)
|
1984-10-12 |
1986-05-12 |
Ishihara Sangyo Kaisha Ltd |
N−ベンゾイル−n′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
DE3541631A1
(de)
*
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
EP0230400A3
(fr)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluorométhyl-pyridyl-2-oxy)phényl-N'-benzoylureds pour combattre des helminths chez le bétail
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
DE3785507T2
(de)
*
|
1986-07-31 |
1993-07-29 |
Beecham Group Plc |
Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
|
EP0262560A3
(fr)
|
1986-09-29 |
1989-07-05 |
Ishihara Sangyo Kaisha, Ltd. |
Composés benzoyl urées
|
US4835180A
(en)
|
1986-10-02 |
1989-05-30 |
Sterling Drug Inc. |
N-(ω-cyanoalkyl)aminophenols and use as inhibitors of lipoxygenase activity
|
NZ221964A
(en)
*
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
EP0264904A3
(fr)
|
1986-10-23 |
1988-08-17 |
Ishihara Sangyo Kaisha, Ltd. |
Compositions pharmaceutiques contenant des dérivés de benzoylurée
|
DE3636190A1
(de)
*
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
EP0314615B1
(fr)
|
1987-10-16 |
1995-04-26 |
Ciba-Geigy Ag |
Pesticides
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
WO1990002112A1
(fr)
|
1988-08-23 |
1990-03-08 |
The Nutrasweet Company |
Arylurees substituees utilisees comme edulcorants de forte puissance
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
JPH02196719A
(ja)
*
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
EP0379915A1
(fr)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Dérivés substitués du phénoxybenzonitrile, procédés pour leur préparation et leur utilisation comme herbicides et comme régulateurs de la croissance des plantes
|
JP3002204B2
(ja)
*
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
US4973675A
(en)
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
EP0425443A1
(fr)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Agent antiparasitaire injectable
|
DK40890D0
(da)
|
1990-02-16 |
1990-02-16 |
Ferrosan As |
Substituerede urinstofforbindelser, deres fremstilling og anvendelse
|
CA2051705A1
(fr)
*
|
1990-06-19 |
1991-12-20 |
Kiyoaki Katano |
Derives de la pyridine, antagonistes de l'angiotensine ii
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
WO1992012966A1
(fr)
*
|
1991-01-21 |
1992-08-06 |
Shionogi Seiyaku Kabushiki Kaisha |
Analogue de 3-benzylidene-1-carbamoyl-2-pyrrolidone
|
US5120842A
(en)
*
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5185438A
(en)
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
US5100883A
(en)
*
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
FI921595A
(fi)
|
1991-04-17 |
1992-10-18 |
American Home Prod |
Rapamycinkarbamater
|
US5118678A
(en)
*
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
US5118677A
(en)
*
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
US5185358A
(en)
*
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
AU2552492A
(en)
|
1991-08-23 |
1993-03-16 |
United States of America as represented by The Secretary Department of Health and Human Services, The |
Raf protein kinase therapeutics
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
US5254582A
(en)
|
1992-02-05 |
1993-10-19 |
Eli Lilly And Company |
Antitumor compositions and methods
|
WO1993018028A1
(fr)
|
1992-03-12 |
1993-09-16 |
Smithkline Beecham Plc |
Derives d'indole utilises comme antagonistes de 5ht¿1c?
|
BR9306421A
(pt)
|
1992-05-28 |
1998-09-15 |
Pfizer |
Novos derivados n-aril e n-heteroariluréia como inbidores da acilcoenzima a:colesterol aciltransferase (acat)
|
US5312820A
(en)
*
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
CN2146707Y
(zh)
|
1992-09-08 |
1993-11-17 |
华东冶金学院 |
高炉软水冷却系统检漏装置
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
WO1994014801A1
(fr)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Derives heterocycliques de l'uree antagonistes de 5ht2c et 5h¿2b?
|
US5512473A
(en)
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
TW272942B
(fr)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
US5378725A
(en)
*
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
US6514745B1
(en)
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
NZ264063A
(en)
*
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
US5504103A
(en)
*
|
1993-08-25 |
1996-04-02 |
Eli Lilly And Company |
Inhibition of phosphatidylinositol 3-kinase with 17 β-hydroxywortmannin and analogs thereof
|
WO1995007922A1
(fr)
|
1993-09-17 |
1995-03-23 |
Smithkline Beecham Corporation |
Proteine fixatrice de medicaments
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
US5869043A
(en)
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
US6361773B1
(en)
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
CA2133815A1
(fr)
*
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition de la phosphatidylinositol 3-kinase au moyen de la viridine, de la demethoxyviridine, du viridiol, du demethoxyviridiol, de la virone et de la wortmannolone et analogues de ces substances.
|
US5596001A
(en)
*
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
DE69433501T2
(de)
|
1993-11-08 |
2004-11-04 |
Smithkline Beecham Corp. |
Oxazole zur behandlung von zytokinvermittelten erkrankungen
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
CH686211A5
(de)
*
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US6811779B2
(en)
*
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5447957A
(en)
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
WO1995033458A1
(fr)
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Composes anti-inflammatoires
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
EP0690344A1
(fr)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Matériau photographique à couleurs à l'halogénure d'argent sensible à la lumière
|
US5480906A
(en)
*
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
US5597719A
(en)
*
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
JPH10510512A
(ja)
|
1994-10-04 |
1998-10-13 |
藤沢薬品工業株式会社 |
尿素誘導体とacat阻害剤としての用途
|
ATE220661T1
(de)
|
1994-10-19 |
2002-08-15 |
Novartis Erfind Verwalt Gmbh |
Antivirale ether von aspartat-protease-substrat- isosteren
|
CA2161376C
(fr)
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Support d'enregistrement thermique multicolore reversible
|
MA23707A1
(fr)
|
1994-10-28 |
1996-07-01 |
Novozymes As |
Procede pour le finissage chimique de polymeres insolubles
|
TW313568B
(fr)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
FR2729567B1
(fr)
*
|
1995-01-20 |
1997-06-13 |
Oreal |
Composition de teinture d'oxydation des fibres keratiniques et procede de teinture mettant en oeuvre cette composition
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
JPH11503110A
(ja)
|
1995-02-17 |
1999-03-23 |
スミスクライン・ビーチャム・コーポレイション |
Il−8受容体拮抗剤
|
US5624937A
(en)
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
DE19512639A1
(de)
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
US5773459A
(en)
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
CA2185737A1
(fr)
*
|
1995-09-18 |
1997-03-19 |
Akira Yoshida |
Derives d'amide et d'uree
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
JP4009681B2
(ja)
|
1995-11-07 |
2007-11-21 |
キリンファーマ株式会社 |
血小板由来成長因子受容体自己リン酸化を阻害するキノリン誘導体ならびにキナゾリン誘導体およびそれらを含有する薬学的組成物
|
CA2241528A1
(fr)
*
|
1995-12-28 |
1997-07-10 |
Hisashi Kanno |
Nouveaux n-(non substitue ou substitue)-4-substitue-6-(non substitue ou substitue) phenoxy-2-pyridinecarboxamides ou thiocarboxamides, leurs procedes de production, et herbicides
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
US6211373B1
(en)
*
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
ATE189814T1
(de)
*
|
1996-04-15 |
2000-03-15 |
Takeda Chemical Industries Ltd |
Hydroxypyridin-derivate, ihre herstellung und ihre pharmazeutische verwendung
|
EA004771B1
(ru)
|
1996-04-23 |
2004-08-26 |
Вертекс Фармасьютикалз Инкорпорейтед |
Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
JPH09301858A
(ja)
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
IL126922A0
(en)
|
1996-05-24 |
1999-09-22 |
Neurosearch As |
Phenyl derivatives containing an acidic group their preparation and their use as chloride channel blockers
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
US6218539B1
(en)
*
|
1996-06-27 |
2001-04-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
CA2258850A1
(fr)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Antagonistes des recepteurs d'il-8
|
EP0907362A4
(fr)
|
1996-06-27 |
1999-12-01 |
Smithkline Beecham Corp |
Antagonistes des recepteurs d'il-8
|
WO1997049286A1
(fr)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Antagonistes des recepteurs d'il-8
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
US5808080A
(en)
|
1996-09-05 |
1998-09-15 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
WO1998017207A1
(fr)
|
1996-10-21 |
1998-04-30 |
Synthes Ag Chur |
Prothese chirurgicale
|
EP0973513A4
(fr)
|
1996-10-23 |
2003-03-19 |
Zymogenetics Inc |
Compositions et methodes pour traiter les etats associes a un deficit osseux
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US6143728A
(en)
|
1996-11-15 |
2000-11-07 |
The Picower Institute For Medical Research |
Guanylhydrazones useful for treating diseases associated with T cell activation
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
AU4966497A
(en)
|
1996-11-18 |
1998-06-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
|
FR2755967B1
(fr)
*
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
KR20000070368A
(ko)
|
1997-01-23 |
2000-11-25 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
인터루킨-8 수용체 길항제
|
US5929250A
(en)
*
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
DE19706061A1
(de)
|
1997-02-07 |
1998-08-13 |
Schering Ag |
Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
|
DE69824837T2
(de)
|
1997-02-12 |
2005-08-25 |
Smithkline Beecham Corp. |
Il-8-rezeptor-antagonisten
|
CN1254335A
(zh)
*
|
1997-04-04 |
2000-05-24 |
辉瑞产品公司 |
烟酰胺衍生物
|
DE69830751T2
(de)
|
1997-04-10 |
2006-05-18 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
|
WO1998049150A1
(fr)
|
1997-04-25 |
1998-11-05 |
Takeda Chemical Industries, Ltd. |
Derives de triazine, production de ces produits et composition agrochimique
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6316479B1
(en)
*
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
WO1998052941A1
(fr)
|
1997-05-22 |
1998-11-26 |
G.D. Searle And Co. |
DERIVES DE PYRAZOLE COMME INHIBITEURS DE KINASE p38
|
BR9809451A
(pt)
|
1997-05-22 |
2000-06-20 |
Searle & Co |
Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38.
|
US6187799B1
(en)
*
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
ES2151467T3
(es)
|
1997-05-23 |
2005-03-01 |
Bayer Corporation |
Arilureas para el tratamiento de enfermedades inflamatorias o inmunomoduladoras.
|
US6344476B1
(en)
*
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
ATE399007T1
(de)
|
1997-05-23 |
2008-07-15 |
Bayer Pharmaceuticals Corp |
Raf kinase hemmer
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
US5985592A
(en)
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
JP2002504909A
(ja)
|
1997-06-13 |
2002-02-12 |
スミスクライン・ビーチャム・コーポレイション |
新規な置換ピラゾールおよびピラゾリン化合物
|
US6093742A
(en)
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
WO1999000370A1
(fr)
|
1997-06-27 |
1999-01-07 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Acide 6-phenoxypicolinique, derives d'alkylidenehydrazide, leur procede de production, et herbicide
|
US6525065B1
(en)
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
AU9802198A
(en)
|
1997-10-21 |
1999-05-10 |
Pharmacia & Upjohn Company |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
ATE337298T1
(de)
|
1997-10-31 |
2006-09-15 |
Aventis Pharma Ltd |
Substituierte anilide
|
AU1367599A
(en)
|
1997-11-03 |
1999-05-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
WO1999026657A1
(fr)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibiteurs de la monoxyde d'azote-synthase
|
AU1407899A
(en)
|
1997-12-01 |
1999-06-16 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
US6174901B1
(en)
*
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
DE1042305T1
(de)
|
1997-12-22 |
2001-04-19 |
Bayer Corp., Pittsburgh |
HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN
|
TR200100918T2
(tr)
|
1997-12-22 |
2001-06-21 |
Bayer Corporation |
Aril ve heteroaril sübstitüentli üreler kullanılarak RAF kinazın inhibe edilmesi
|
US7329670B1
(en)
*
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
US20120046290A1
(en)
|
1997-12-22 |
2012-02-23 |
Jacques Dumas |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
JP2001526222A
(ja)
|
1997-12-22 |
2001-12-18 |
バイエル コーポレイション |
アリールおよびヘテロアリール置換複素環尿素を使用するp38キナーゼ活性の阻害
|
US7517880B2
(en)
*
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
CA2315646C
(fr)
|
1997-12-22 |
2010-02-09 |
Bayer Corporation |
Inhibition de raf kinase au moyen de diphenylurees substituees symetriques et asymetriques
|
HUP0101704A3
(en)
|
1997-12-22 |
2002-12-28 |
Bayer Corp Pittsburgh |
Kinease substituted heterocyclic ureas with raf inhibition activity and pharmaceutical compositions containing them
|
DE1041982T1
(de)
|
1997-12-22 |
2001-06-07 |
Bayer Corp., Pittsburgh |
HEMMUNG DER p38 KINASE AKTIVITÄT DURCH SUBSTITUIERTEN HETEROCYCLISCHEN HARNSTOFFEN
|
WO1999033458A1
(fr)
|
1997-12-25 |
1999-07-08 |
Daiichi Pharmaceutical Co., Ltd. |
Composition medicinale pour administration percutanee
|
CA2284864A1
(fr)
*
|
1998-01-21 |
1999-07-29 |
Zymogenetics, Inc. |
Dialkylurees utilisees en tant que substances imitant la calcitonine
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
EP1057031B1
(fr)
|
1998-02-18 |
2003-04-23 |
Theryte Limited |
Traitement du cancer
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
US6413773B1
(en)
*
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
WO2000017175A1
(fr)
|
1998-09-18 |
2000-03-30 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de p38
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
CN1342077A
(zh)
|
1998-11-06 |
2002-03-27 |
诺尔股份公司 |
抑制血管渗透性过高的形成
|
AU2156600A
(en)
|
1998-11-25 |
2000-06-13 |
Cold Spring Harbor Laboratory |
Methods and reagents for increasing proliferative capacity and preventing replicative senescence
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
EP1140087A4
(fr)
|
1998-12-18 |
2002-04-03 |
Du Pont Pharm Co |
N-ureidoalkyl-piperidines utilisees en tant que modulateurs de l'activite des recepteurs des chimiokines
|
US6331541B1
(en)
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
ES2244231T3
(es)
|
1998-12-25 |
2005-12-01 |
Teikoku Hormone Mfg. Co., Ltd. |
Derivados de aminopirazol.
|
ATE556713T1
(de)
*
|
1999-01-13 |
2012-05-15 |
Bayer Healthcare Llc |
Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
RU2319693C9
(ru)
|
1999-01-13 |
2008-08-20 |
Байер Копэрейшн |
Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
WO2000042012A1
(fr)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
DIPHENYLUREES A SUBSTITUANTS φ-CARBOXYARYLES, INHIBITRICES DE KINASE RAF
|
TWI284642B
(en)
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
WO2000043366A1
(fr)
|
1999-01-22 |
2000-07-27 |
Kirin Beer Kabushiki Kaisha |
Derives de quinoline et derives de quinazoline
|
DE60013250T2
(de)
|
1999-02-12 |
2005-09-08 |
Smithkline Beecham P.L.C., Brentford |
Phenylharnstoff- und Phenylthioharnstoffderivate als Orexinrezeptorantagonisten
|
EP1157026A1
(fr)
|
1999-02-22 |
2001-11-28 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Derives polycyclo heterocycliques utilises en tant qu'agents anti-inflammatoires
|
CN1156452C
(zh)
*
|
1999-03-12 |
2004-07-07 |
贝林格尔·英格海姆药物公司 |
作为消炎剂的化合物
|
ES2251360T3
(es)
|
1999-03-12 |
2006-05-01 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Compuestos heterociclicos aromaticos en calidad de agentes antiinflamatorios.
|
AP1498A
(en)
|
1999-03-19 |
2005-11-21 |
Vertex Pharma |
Inhibitors of impdh enzyme.
|
CA2368631A1
(fr)
|
1999-03-26 |
2000-10-05 |
Euro-Celtique S.A. |
Pyrazoles, imidazoles, oxazoles, thiazoles et pyrroles aryle substitues et leurs utilisations
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
DE60009480T2
(de)
|
1999-05-05 |
2005-09-01 |
Aventis Pharma Ltd., West Malling |
Harnstoffe als modulatoren der zelladhäsion
|
EP2042194A3
(fr)
|
1999-05-14 |
2009-04-22 |
Imclone Systems, Inc. |
Traitement des tumeurs humaines réfractaires avec des antagonistes de récepteur de facteur de croissance épidermique
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
WO2001004789A1
(fr)
|
1999-07-09 |
2001-01-18 |
Sakai, Yasue |
Dispositif de generation de donnees sur forme d'onde a fonction d'echantillonnage
|
ES2253233T3
(es)
|
1999-07-09 |
2006-06-01 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Procedimiento para sintesis de compuestos de urea heteroaril sustituidos.
|
CA2380389A1
(fr)
|
1999-07-26 |
2001-02-01 |
Banyu Pharmaceutical Co., Ltd. |
Derives de biaryluree
|
WO2001009088A1
(fr)
|
1999-07-28 |
2001-02-08 |
Kirin Beer Kabushiki Kaisha |
Derives d'uree utilises comme inhibiteurs du recepteur ccr-3
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
AU1201801A
(en)
|
1999-10-15 |
2001-08-07 |
Van Kampen Group, Inc., The |
Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
|
AU1617901A
(en)
|
1999-11-16 |
2001-05-30 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Urea derivatives as anti-inflammatory agents
|
US6525046B1
(en)
*
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
BR0108085A
(pt)
|
2000-02-07 |
2003-03-18 |
Abbott Gmbh & Co Kg |
Derivados de 2-benzotiazolil uréia e seu uso como inibidores da cinase protéica
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
PT1259248E
(pt)
|
2000-03-02 |
2005-04-29 |
Ludwig Inst Cancer Res |
Metodos para tratar, rastrear e detectar cancros que expressam o factor de crescimento vascular endotelial d
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
EP1275386A1
(fr)
|
2000-04-19 |
2003-01-15 |
Fujisawa Pharmaceutical Co., Ltd. |
Dispersion solide a meilleur pouvoir absorbant
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
WO2002007008A1
(fr)
|
2000-04-28 |
2002-01-24 |
Ubink Cornelis Hubertus Johann |
Systeme d'approvisionnement en reseau
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
EP1311277A4
(fr)
|
2000-07-18 |
2004-08-25 |
Joslin Diabetes Center Inc |
Procede de modulation de fibrose
|
WO2002007772A2
(fr)
|
2000-07-24 |
2002-01-31 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Formes posologiques orales ameliorees de 1-(5-tert-butyl-2-p-tolyl-2h-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphtalene-1-yl]-uree
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
RU2003105882A
(ru)
|
2000-08-04 |
2005-01-20 |
Лома Линда Юниверсити Медикал Сентер (Us) |
Упорядоченный железосодержащий белок-2 в качестве диагностического средства при нейродегенеративных заболеваниях
|
AU8323701A
(en)
|
2000-08-11 |
2002-02-25 |
John Cochran |
Inhibitors of p38
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
WO2002014338A1
(fr)
|
2000-08-17 |
2002-02-21 |
The Kitasato Institute |
Nouveaux derives de pseudoerythromycine
|
CZ2003468A3
(cs)
|
2000-08-31 |
2004-05-12 |
Pfizeráproductsáinc |
Deriváty pyrazolu a jejich použití jako inhibitorů proteinkinázy
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
RU2264389C3
(ru)
|
2000-10-20 |
2018-06-01 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Азотсодержащие ароматические производные, их применение, лекарственное средство на их основе и способ лечения
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
JP2004513935A
(ja)
|
2000-11-17 |
2004-05-13 |
ノボ ノルディスク アクティーゼルスカブ |
グルカゴンアンタゴニスト/逆アゴニスト
|
CN1525889A
(zh)
|
2000-11-27 |
2004-09-01 |
����ˡ�A�������� |
分类物品的系统、方法及程序
|
SI1337521T1
(sl)
|
2000-11-28 |
2006-12-31 |
Pfizer Prod Inc |
Soli izotiazol-4-karboksamida in njihova uporaba kot antihiperproliferacijska sredstva
|
AU2002232439A1
(en)
|
2000-11-29 |
2002-06-11 |
Glaxo Group Limited |
Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
|
BR0116431A
(pt)
|
2000-12-21 |
2004-06-22 |
Glaxo Group Ltd |
Antibióticos de macrolìdeos
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
WO2002059080A2
(fr)
|
2001-01-25 |
2002-08-01 |
Guilford Pharmaceuticals Inc. |
Composes de liaison de la cyclophiline carboxylique trisubstituee et leur utilisation
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
WO2002059081A2
(fr)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Derives d'uree en tant qu'inhibiteurs du recepteur ccr-3
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
CN1296043C
(zh)
|
2001-02-19 |
2007-01-24 |
诺瓦提斯公司 |
式i的雷帕霉素化合物在制备用于治疗实体瘤的药物组合物中的用途
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
AU2002306618B2
(en)
|
2001-03-07 |
2006-11-09 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
CA2441501C
(fr)
|
2001-03-23 |
2010-09-14 |
Bayer Corporation |
Inhibiteurs de rho-kinase
|
MXPA03009361A
(es)
|
2001-04-13 |
2004-01-29 |
Boehringer Ingelheim Pharma |
Compuestos de urea utilies como agentes anti-inflamatorios.
|
WO2002083628A1
(fr)
|
2001-04-13 |
2002-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Composes benzo-fusionnes a disubstitution en positions 1,4
|
DE60218445T2
(de)
|
2001-04-20 |
2007-11-29 |
Bayer Pharmaceuticals Corp., West Haven |
Inhibierung der raf-kinase durch chinolin-, isochinolin- oder pyridin-harnstoffe
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
JP2004538266A
(ja)
|
2001-04-27 |
2004-12-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ピラゾール由来のキナーゼインヒビター
|
EP1392661A1
(fr)
|
2001-05-16 |
2004-03-03 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Derives de diaryluree utilisables en tant qu'agents anti-inflammatoires
|
JP2004536845A
(ja)
|
2001-07-11 |
2004-12-09 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
サイトカイン媒介疾患の治療方法
|
US7371736B2
(en)
|
2001-11-07 |
2008-05-13 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
|
SE0103838D0
(sv)
|
2001-11-16 |
2001-11-16 |
Astrazeneca Ab |
Pharmaceutical formulation & product
|
EP2295057B1
(fr)
|
2001-12-03 |
2013-01-23 |
Bayer HealthCare LLC |
Composés de type urée aryle combines à d'autres agents cytostatiques ou cytotoxiques et servant à traiter des cancers humains
|
CA2466762A1
(fr)
*
|
2001-12-04 |
2003-06-12 |
Onyx Pharmaceuticals, Inc. |
Inhibiteurs de la voie raf-mek-erk pour traiter le cancer
|
ES1050706Y
(es)
|
2001-12-12 |
2002-08-16 |
Climastar Thermostone S L |
Convector electrico mejorado
|
JP4643909B2
(ja)
|
2001-12-21 |
2011-03-02 |
ザ ウェルカム トラスト リミテッド |
遺伝子
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
WO2003060111A2
(fr)
|
2001-12-24 |
2003-07-24 |
Catalyst Biomedica Limited |
Genes
|
US20080108672A1
(en)
*
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US20050090474A1
(en)
|
2002-01-16 |
2005-04-28 |
Zvi Naor |
Methods and compositions for enhancing and inhibiting fertilization
|
WO2003062225A1
(fr)
|
2002-01-23 |
2003-07-31 |
Bayer Pharmaceuticals Corporation |
Derives pyrimidine en tant qu'inhibiteurs de kinase rho
|
ATE381557T1
(de)
|
2002-01-23 |
2008-01-15 |
Bayer Pharmaceuticals Corp |
Rho-kinase inhibitoren
|
US20050026868A1
(en)
|
2003-07-11 |
2005-02-03 |
Metcalf Chester A. |
Phosphorus-containing macrocycles
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
AU2003209119A1
(en)
|
2002-02-11 |
2003-09-04 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
CA2475703C
(fr)
|
2002-02-11 |
2016-12-20 |
Bayer Pharmaceuticals Corporation |
Urees aryliques a activite inhibitrice d'angiogenese
|
US7928277B1
(en)
|
2002-02-11 |
2011-04-19 |
Cox Jr Henry Wilmore |
Method for reducing contamination
|
CN1318404C
(zh)
|
2002-02-11 |
2007-05-30 |
拜耳制药公司 |
作为激酶抑制剂的芳基脲类化合物
|
US7645878B2
(en)
*
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
DE60322544D1
(de)
|
2002-08-27 |
2008-09-11 |
Merck Patent Gmbh |
Glycinamid-derivate als raf-kinase-hemmer
|
CN100497302C
(zh)
|
2002-09-05 |
2009-06-10 |
神经研究公司 |
二芳基脲衍生物和它们作为氯通道阻滞剂的用途
|
JP4690889B2
(ja)
|
2002-10-24 |
2011-06-01 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
メチレン尿素誘導体
|
CA2504933C
(fr)
|
2002-11-06 |
2012-10-16 |
Dana-Farber Cancer Institute, Inc. |
Procedes et compositions de traitement du cancer au moyen d'inhibiteurs de la proteasome
|
BR0316279A
(pt)
|
2002-11-15 |
2005-10-11 |
Novartis Ag |
Compostos orgânicos
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
GB0317227D0
(en)
|
2003-07-23 |
2003-08-27 |
Pfizer Ltd |
Treatment of male sexual dysfunction
|
UY28213A1
(es)
|
2003-02-28 |
2004-09-30 |
Bayer Pharmaceuticals Corp |
Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
|
CA2516624C
(fr)
*
|
2003-02-28 |
2013-05-14 |
Bayer Pharmaceuticals Corporation |
Derives de 2-oxo-1,3,5-perhydrotriazapine destines au traitement de maladies hyperproliferatives, angiogeniques et inflammatoires
|
CA2516931C
(fr)
|
2003-02-28 |
2014-09-09 |
Bayer Pharmaceuticals Corporation |
Nouveaux derives bicycliques d'uree utiles dans le traitement du cancer et d'autres troubles
|
CA2516627A1
(fr)
|
2003-02-28 |
2004-09-16 |
Bayer Pharmaceuticals Corporation |
Derives de pyridine substitues utilises pour traiter des cancers et d'autres troubles
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
JP2006521304A
(ja)
|
2003-03-24 |
2006-09-21 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
rafキナーゼ阻害剤として有用なオキサミド誘導体
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
DK1626714T3
(da)
|
2003-05-20 |
2007-10-15 |
Bayer Pharmaceuticals Corp |
Dirarylurinstoffer mod sygdomme medieret af PDGFR
|
JP2006526606A
(ja)
|
2003-06-05 |
2006-11-24 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
治療薬としてのシクロアルキル及びヘテロシクロアルキル置換されるベンゾチオフェン
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
GB2403151A
(en)
|
2003-06-27 |
2004-12-29 |
Intermark Medical Innovations |
A device for rectal lavage
|
WO2005002673A1
(fr)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Inhibiteurs de raf kinase
|
WO2005005389A2
(fr)
|
2003-07-07 |
2005-01-20 |
Merck Patent Gmbh |
Derives de malonamide
|
EP1646634B1
(fr)
|
2003-07-08 |
2008-11-12 |
Novartis AG |
Utilisation de rapamycine et de derives de rapamycine pour traiter les pertes de masse osseuse
|
WO2005004864A1
(fr)
|
2003-07-11 |
2005-01-20 |
Merck Patent Gmbh |
Derives de benzimidazoles utilises comme inhibiteurs de kinase raf
|
WO2005004863A1
(fr)
|
2003-07-11 |
2005-01-20 |
Merck Patent Gmbh |
Benzimidazole carboxamides utilises en tant qu'inhibiteurs de la kinase raf
|
WO2005009367A2
(fr)
|
2003-07-17 |
2005-02-03 |
Ambit Biosciences Corporation |
Traitement de maladies au moyen d'inhibiteurs de kinase
|
GB0317229D0
(en)
|
2003-07-23 |
2003-08-27 |
Pfizer Ltd |
Improved process
|
ME00294B
(fr)
|
2003-07-23 |
2011-05-10 |
Bayer Pharmaceuticals Corp |
Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques
|
AR045134A1
(es)
|
2003-07-29 |
2005-10-19 |
Smithkline Beecham Plc |
Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
CA2537991A1
(fr)
|
2003-09-23 |
2005-03-31 |
Novartis Ag |
Polytherapie combinant un inhibiteur des recepteurs du facteur vegf avec un agent chimiotherapeutique
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
CA2542494A1
(fr)
*
|
2003-10-15 |
2005-05-06 |
Bayer Healthcare Ag |
Derives de tetrahydro-naphthalene et d'uree
|
EP1680122A1
(fr)
|
2003-10-16 |
2006-07-19 |
Chiron Corporation |
Quinoxalines, quinolines, isoquinolines et quinazolines 2,6-bisubstituees servant d'inhibiteurs a la kinase raf pour le traitement du cancer
|
ATE435015T1
(de)
|
2003-10-16 |
2009-07-15 |
Novartis Vaccines & Diagnostic |
Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
|
DE10349587A1
(de)
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
US20050171171A1
(en)
|
2003-11-13 |
2005-08-04 |
Ambit Biosciences Corporation |
Amide derivatives as FLT-3 modulators
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
TR200604485T1
(tr)
|
2003-12-09 |
2007-01-22 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Bir immün tepkinin bastırılması veya proliferatif bir hastalığın tedavisi
|
EP1692110A1
(fr)
|
2003-12-10 |
2006-08-23 |
MERCK PATENT GmbH |
Derives de diacylhydrazine
|
BRPI0507198A
(pt)
|
2004-01-30 |
2007-06-26 |
Merck Patent Gmbh |
derivados de bisariluréia
|
US20050267060A1
(en)
|
2004-03-19 |
2005-12-01 |
The Penn State Research Foundation |
Combinatorial methods and compositions for treatment of melanoma
|
JP2007535565A
(ja)
|
2004-04-30 |
2007-12-06 |
バイエル ファーマシューティカルス コーポレーション |
癌の治療に有用な置換ピラゾリル尿素誘導体
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
ATE395905T1
(de)
*
|
2004-08-27 |
2008-06-15 |
Bayer Pharmaceuticals Corp |
Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs
|
US7745446B2
(en)
|
2004-09-06 |
2010-06-29 |
Bayer Schering Pharma Aktiengesellschaft |
Pyrazolo[1,5-c]pyrimidines
|
NZ553804A
(en)
|
2004-09-29 |
2010-07-30 |
Bayer Schering Pharma Ag |
Thermodynamically stable form of bay 43-9006 tosylate
|
EP1797037B1
(fr)
|
2004-09-29 |
2014-12-17 |
Bayer HealthCare LLC |
Procede de preparation de 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-n-methylpyridine-2-carboxamide
|
WO2006076592A1
(fr)
|
2005-01-14 |
2006-07-20 |
Cgi Pharmaceuticals, Inc. |
Urees a substitution 1,3-diaryle, modulateurs de l'activite de kinases
|
US9737488B2
(en)
|
2005-03-07 |
2017-08-22 |
Bayer Healthcare Llc |
Pharmaceutical composition for the treatment of cancer
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
WO2006125539A2
(fr)
|
2005-05-27 |
2006-11-30 |
Bayer Healthcare Ag |
Therapie de combinaisons comprenant des urees diaryle destinee a traiter des maladies
|
KR20080018908A
(ko)
|
2005-05-27 |
2008-02-28 |
바이엘 헬스케어 아게 |
암 치료용 디아릴 우레아 화합물 및 pi3, akt 키나제또는 mtor 억제제 (라파마이신)를 포함하는 병용요법
|
WO2007015947A2
(fr)
|
2005-07-29 |
2007-02-08 |
Bayer Healthcare Llc |
Methodes et trousses pour la prediction du succes therapeutique, de la survie sans recidive et globale dans des therapies du cancer
|
RS52383B
(en)
|
2005-09-21 |
2012-12-31 |
4Sc Ag |
NEW SULFONYLPYROLS AS HDAC INHIBITORS
|
US20090221010A1
(en)
|
2005-10-21 |
2009-09-03 |
Elting James J |
Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
|
US8329408B2
(en)
*
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
CA2627875A1
(fr)
*
|
2005-10-31 |
2007-05-10 |
Bayer Pharmaceuticals Corporation |
Diaryle-urees et combinaisons
|
US20090215835A1
(en)
|
2005-10-31 |
2009-08-27 |
Scott Wilhelm |
Treatment of cancer with sorafenib
|
KR20080073729A
(ko)
|
2005-11-02 |
2008-08-11 |
바이엘 헬스케어 엘엘씨 |
암의 예측 및 예후 방법, 및 암 치료 모니터링 방법
|
AU2006312714A1
(en)
|
2005-11-10 |
2007-05-18 |
Bayer Schering Pharma Aktiengesellschaft |
Diaryl urea for treating pulmonary hypertension
|
WO2007054215A1
(fr)
|
2005-11-10 |
2007-05-18 |
Bayer Healthcare Ag |
Diaryle-urees permettant de traiter l'hypertension pulmonaire
|
WO2007059155A1
(fr)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Traitement de cancers a resistance a des agents chimiotherapeutiques
|
WO2007059154A2
(fr)
|
2005-11-14 |
2007-05-24 |
Bayer Healthcare Llc |
Traitement de cancers a resistance acquise a des inhibiteurs de kit
|
CN101454668A
(zh)
|
2005-11-14 |
2009-06-10 |
拜耳医药保健有限责任公司 |
癌症预测与预后以及监测癌症治疗的方法
|
WO2007064872A2
(fr)
|
2005-12-01 |
2007-06-07 |
Bayer Healthcare Llc |
Composes de l'uree utilises dans le traitement du cancer
|
EP1962829A1
(fr)
|
2005-12-15 |
2008-09-03 |
Bayer HealthCare AG |
Urees de diaryle pour le traitement des infections virales
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
WO2007068380A1
(fr)
|
2005-12-15 |
2007-06-21 |
Bayer Healthcare Ag |
Diaryle-uree pour le traitement d'infections virales
|
EP1973897B1
(fr)
|
2005-12-21 |
2014-05-21 |
Bayer Intellectual Property GmbH |
Dérivés substitués de la pyrimidine utilisables dans le traitement du cancer et d'autres maladies
|
US20090197922A1
(en)
|
2006-01-24 |
2009-08-06 |
The University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
JP2009532029A
(ja)
|
2006-03-31 |
2009-09-10 |
バイエル・ヘルスケア・エルエルシー |
癌の予報および予後方法および癌治療のモニタリング
|
EP2338488A1
(fr)
*
|
2006-05-26 |
2011-06-29 |
Bayer HealthCare, LLC |
Associations de médicaments comportant des urées de diaryle
|
AR062927A1
(es)
|
2006-10-11 |
2008-12-17 |
Bayer Healthcare Ag |
4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
|
CA2668748A1
(fr)
*
|
2006-11-09 |
2008-05-15 |
Bayer Schering Pharma Aktiengesellschaft |
Polymorphe iii de 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
|
JP2010509289A
(ja)
|
2006-11-09 |
2010-03-25 |
アボット ゲーエムベーハー ウント コンパニー カーゲー |
チロシンキナーゼ阻害剤の経口投与用薬学的剤形
|
CA2669158A1
(fr)
*
|
2006-11-14 |
2008-05-22 |
Bayer Schering Pharma Aktiengesellschaft |
Polymorphe ii de 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
|
DK2111401T3
(da)
|
2006-12-20 |
2011-05-30 |
Bayer Healthcare Llc |
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}carbamoyl)-amino]-3-fluorphenoxy}-N-methylpyridin-2-carboxamid samt prodrug og salte heraf til behandling af cancer
|
US20100150863A1
(en)
|
2006-12-20 |
2010-06-17 |
Bayer Pharmaceuticals Corporation |
Hydroxy methyl phenyl pyrazolyl urea compound useful in treatment of cancer
|
WO2008089389A2
(fr)
|
2007-01-19 |
2008-07-24 |
Bayer Healthcare Llc |
Traitement de cancers à résistance acquise aux inhibiteurs kit
|
EP2114403A2
(fr)
|
2007-01-19 |
2009-11-11 |
Bayer Healthcare, LLC |
Traitement de cancers présentant une résistance à des agents chimiothérapeutiques
|
US8110887B2
(en)
|
2007-06-21 |
2012-02-07 |
Sharp Kabushiki Kaisha |
Photodetector and display device provided with the same
|
JP5076072B2
(ja)
|
2008-03-24 |
2012-11-21 |
矢崎総業株式会社 |
圧着端子、及びこの圧着端子を用いた圧着構造
|
EP2296641A1
(fr)
|
2008-06-25 |
2011-03-23 |
Bayer Schering Pharma Aktiengesellschaft |
Diaryle-urée pour le traitement de l'insuffisance cardiaque
|
WO2010048304A2
(fr)
|
2008-10-21 |
2010-04-29 |
Bayer Healthcare Llc |
Identification de gènes signature associés à un carcinome hépatocellulaire
|
JP5077375B2
(ja)
|
2010-02-26 |
2012-11-21 |
井関農機株式会社 |
コンバイン
|